no code implementations • 3 Dec 2022 • Chao Pang, Yu Wang, Yi Jiang, Ruheng Wang, Ran Su, Leyi Wei
Moreover, case study results on targeted molecule generation for the SARS-CoV-2 main protease (Mpro) show that by integrating molecule docking into our model as chemical priori, we successfully generate new small molecules with desired drug-like properties for the Mpro, potentially accelerating the de novo design of Covid-19 drugs.